Cytosorbents Corp

NASDAQ:CTSO   4:00:00 PM EDT
0.95
+0.02 (+2.16%)
4:12:36 PM EDT: $0.99 +0.04 (+4.21%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)49.60M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9.58 Million
Adjusted EPS-$0.13
See more estimates
10-Day MA$0.92
50-Day MA$0.97
200-Day MA$1.90
See more pivots

Cytosorbents Corp Stock, NASDAQ:CTSO

305 College Road East, Suite K, Princeton, New Jersey 08540
United States of America
Phone: +1.732.329.8885
Number of Employees: 186

Description

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.